Table 3.
Incidence of complications.
| First Authors | Complications | p value |
|---|---|---|
| Peppelenbosch [10] | Higher in rEVAR groups | N/A |
| Peppelenbosch [45] | Lower in rEVAR group | ≤.02 (No difference @ 3 months) |
| Brahmbhatt [88] | Lower in rEVAR group | <.001 |
| Resch [39] | Lower in rEVAR group | N/A |
| Alsac [26] | Lower in rEVAR group | N/A |
| Castelli [27] | Lower in rEVAR group | N/A |
| Brandt [44] | Lower in rEVAR group | N/A |
| Dalainas [57] | Lower in rEVAR group | N/A |
| Lesperance [58] | Lower in rEVAR group | N/A |
| Giles [60] | Lower in rEVAR group | N/A |
| McPhee [62] | Lower in rEVAR group | N/A |
| Van Schaik [72] | Lower in rEVAR group | N/A |
| Nedeau [77] | Lower in rEVAR group | N/A |
| Gunnarsson [22] | Lower in rEVAR group | N/A |
| Desgranges [86] | Lower in rEVAR group | N/A |
| Improve Trial Investigators [23] | Lower in rEVAR group | N/A |
| Huang [19] | Lower in rEVAR group | N/A |
| Noorani [78] | Lower in rEVAR group | <.001 |
| Giles [89] | Lower in rEVAR group | <.01 |
| Speicher [84] | Lower in rEVAR group | <.001 |
| Park [79] | Lower in rEVAR group | OR=0.535; CI, 0.395–0.724 |
| Ohki [36] | Lower in rEVAR group | N/A |
| van Beek [24] | No difference | N/A |
| Greco [35] | Lower in rEVAR group (regarding systemic complications; no difference in postoperative method-related complications) | N/A |
| Arya [47] | No difference | N/A |
| Hinchcliffe [37] | No difference | N/A |
| Anain [56] | No difference | N/A |
| Saqib [25] | No difference | N/A |
| Wu [82] | No difference | N/A |
| Larzon [28] | No difference | N/A |
| Franks [48] | No difference | .28 |
| Ockert [53] | No difference | .9 |
| Coppi [49] | No difference | N/A |
| Reimerink [81] | No difference | .56 @ 30 days;.71 @ 6 months |
| Vaddenini [43] | No difference | N/A |
| Lee [41] | No difference | .26 |
| Visser [29] | No difference | .40 in-hospital;.36 @ 1 year |
| Wibmer [30] | No difference | N/A |
| Lyons [69] | No difference | NS |